Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)
INR 1829.4
(-0.16%)
INR 1829.4
(-0.16%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 154.18 Billion INR | -34.03% |
| 2022 | 233.73 Billion INR | 28.13% |
| 2021 | 182.41 Billion INR | 8.35% |
| 2020 | 168.35 Billion INR | -0.49% |
| 2019 | 169.18 Billion INR | 14.91% |
| 2018 | 147.22 Billion INR | 11.94% |
| 2017 | 131.52 Billion INR | 9.42% |
| 2016 | 120.2 Billion INR | -5.97% |
| 2015 | 127.83 Billion INR | 0.94% |
| 2014 | 126.65 Billion INR | 115.4% |
| 2013 | 58.79 Billion INR | 43.25% |
| 2012 | 41.04 Billion INR | 34.62% |
| 2011 | 30.48 Billion INR | 37.03% |
| 2010 | 22.24 Billion INR | 59.91% |
| 2009 | 13.91 Billion INR | -5.19% |
| 2008 | 14.67 Billion INR | 41.79% |
| 2007 | 10.34 Billion INR | 43.38% |
| 2006 | 7.21 Billion INR | 30.6% |
| 2005 | 5.52 Billion INR | 21.74% |
| 2004 | 4.54 Billion INR | 24.45% |
| 2003 | 3.64 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 38.64 Billion INR | -8.24% |
| 2024 Q2 | 73.85 Billion INR | 11.49% |
| 2023 Q4 | 42.11 Billion INR | -37.04% |
| 2023 Q3 | 66.89 Billion INR | 0.82% |
| 2023 Q2 | 66.35 Billion INR | 4.52% |
| 2023 Q1 | 63.48 Billion INR | 0.49% |
| 2023 FY | 154.18 Billion INR | -34.03% |
| 2022 FY | 233.73 Billion INR | 28.13% |
| 2022 Q4 | 63.17 Billion INR | 6.19% |
| 2022 Q2 | 55.13 Billion INR | -1.43% |
| 2022 Q1 | 55.93 Billion INR | 60.24% |
| 2022 Q3 | 59.49 Billion INR | 7.92% |
| 2021 Q4 | 34.9 Billion INR | -31.7% |
| 2021 FY | 182.41 Billion INR | 8.35% |
| 2021 Q1 | 47.82 Billion INR | 38.23% |
| 2021 Q2 | 48.58 Billion INR | 1.61% |
| 2021 Q3 | 51.1 Billion INR | 5.17% |
| 2020 FY | 168.35 Billion INR | -0.49% |
| 2020 Q4 | 34.59 Billion INR | -25.54% |
| 2020 Q3 | 46.45 Billion INR | 3.21% |
| 2020 Q2 | 45.01 Billion INR | 6.44% |
| 2020 Q1 | 42.29 Billion INR | 17.85% |
| 2019 Q1 | 43.3 Billion INR | 39.57% |
| 2019 Q2 | 43.73 Billion INR | 0.99% |
| 2019 FY | 169.18 Billion INR | 14.91% |
| 2019 Q3 | 46.26 Billion INR | 5.78% |
| 2019 Q4 | 35.88 Billion INR | -22.43% |
| 2018 Q2 | 39.84 Billion INR | 4.11% |
| 2018 FY | 147.22 Billion INR | 11.94% |
| 2018 Q4 | 31.02 Billion INR | -18.55% |
| 2018 Q3 | 38.09 Billion INR | -4.39% |
| 2018 Q1 | 38.26 Billion INR | 3.08% |
| 2017 Q1 | 37.4 Billion INR | 9.34% |
| 2017 FY | 131.52 Billion INR | 9.42% |
| 2017 Q4 | 37.12 Billion INR | 9.7% |
| 2017 Q3 | 33.84 Billion INR | -8.42% |
| 2017 Q2 | 36.95 Billion INR | -1.2% |
| 2016 Q1 | 37.9 Billion INR | -3.44% |
| 2016 FY | 120.2 Billion INR | -5.97% |
| 2016 Q4 | 34.2 Billion INR | -2.76% |
| 2016 Q3 | 35.17 Billion INR | -1.23% |
| 2016 Q2 | 35.61 Billion INR | -6.06% |
| 2015 Q2 | 36.16 Billion INR | 5.43% |
| 2015 Q3 | 34.08 Billion INR | -5.76% |
| 2015 Q1 | 34.3 Billion INR | -18.62% |
| 2015 Q4 | 39.26 Billion INR | 15.19% |
| 2015 FY | 127.83 Billion INR | 0.94% |
| 2014 Q4 | 42.15 Billion INR | 126.95% |
| 2014 Q2 | 19.45 Billion INR | 24.25% |
| 2014 Q1 | 15.66 Billion INR | 48.06% |
| 2014 FY | 126.65 Billion INR | 115.4% |
| 2014 Q3 | 18.57 Billion INR | -4.55% |
| 2013 Q1 | 15.03 Billion INR | 69.68% |
| 2013 Q2 | 16.63 Billion INR | 10.66% |
| 2013 Q3 | 16.34 Billion INR | -1.79% |
| 2013 Q4 | 10.57 Billion INR | -35.26% |
| 2013 FY | 58.79 Billion INR | 43.25% |
| 2012 Q1 | 9.93 Billion INR | 63.24% |
| 2012 Q3 | 11.16 Billion INR | 3.04% |
| 2012 Q4 | 8.86 Billion INR | -20.61% |
| 2012 FY | 41.04 Billion INR | 34.62% |
| 2012 Q2 | 10.83 Billion INR | 8.99% |
| 2011 Q4 | 6.08 Billion INR | -30.87% |
| 2011 Q3 | 8.8 Billion INR | 8.0% |
| 2011 Q2 | 8.15 Billion INR | 9.54% |
| 2011 Q1 | 7.44 Billion INR | 0.0% |
| 2011 FY | 30.48 Billion INR | 37.03% |
| 2010 FY | 22.24 Billion INR | 59.91% |
| 2009 FY | 13.91 Billion INR | -5.19% |
| 2008 FY | 14.67 Billion INR | 41.79% |
| 2007 FY | 10.34 Billion INR | 43.38% |
| 2006 FY | 7.21 Billion INR | 30.6% |
| 2005 FY | 5.52 Billion INR | 21.74% |
| 2004 FY | 4.54 Billion INR | 24.45% |
| 2003 FY | 3.64 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sigachi Industries Limited | 579.88 Million INR | -26488.249% |
| Ind-Swift Limited | 946.56 Million INR | -16188.525% |
| Innova Captab Limited | 931.03 Million INR | -16460.347% |
| Aarti Drugs Limited | 1.16 Billion INR | -13106.387% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -4915.021% |
| Bajaj HealthCare Limited | 985.34 Million INR | -15547.494% |
| Sakar Healthcare Limited | 204.07 Million INR | -75450.057% |
| Aurobindo Pharma Limited | 55.65 Billion INR | -177.017% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -5936.639% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -6133.345% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -94940.19% |
| Morepen Laboratories Limited | 1.98 Billion INR | -7657.77% |
| Sequent Scientific Limited | 2.9 Billion INR | -5213.298% |
| Wanbury Limited | 978.96 Million INR | -15649.454% |
| Laurus Labs Limited | 11.9 Billion INR | -1194.579% |
| Nectar Lifesciences Limited | 932.7 Million INR | -16430.696% |
| Gufic Biosciences Limited | 1.18 Billion INR | -12893.699% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -1224.507% |
| Alembic Limited | 872.45 Million INR | -17572.117% |
| Hikal Limited | 4.46 Billion INR | -3354.048% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -871.548% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | -228.378% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -6905.08% |
| Themis Medicare Limited | 1.12 Billion INR | -13595.334% |
| RPG Life Sciences Limited | 1.63 Billion INR | -9327.197% |
| Lupin Limited | 125.09 Billion INR | -23.251% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -7262.898% |
| Wockhardt Limited | 8.48 Billion INR | -1718.182% |
| Vaishali Pharma Limited | 84.02 Million INR | -183386.415% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -35057.177% |
| NATCO Pharma Limited | 10.05 Billion INR | -1432.927% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -966.707% |
| FDC Limited | 3.49 Billion INR | -4305.499% |
| Divi's Laboratories Limited | 14.17 Billion INR | -988.086% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -37284.022% |
| Eris Lifesciences Limited | 4.94 Billion INR | -3019.233% |
| Windlas Biotech Limited | 1 Billion INR | -15218.457% |
| Mankind Pharma Limited | 29.27 Billion INR | -426.705% |
| Venus Remedies Limited | 1.91 Billion INR | -7945.874% |
| ZIM Laboratories Limited | 1.01 Billion INR | -15119.444% |
| Neuland Laboratories Limited | 2.92 Billion INR | -5162.634% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | -942.294% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -14253.362% |
| Zydus Lifesciences Limited | 125.21 Billion INR | -23.138% |
| Bal Pharma Limited | 555.62 Million INR | -27649.205% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | -60.81% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -264417.139% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -6990.448% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -10763.825% |
| Shilpa Medicare Limited | 3.33 Billion INR | -4524.284% |
| Orchid Pharma Limited | 800.77 Million INR | -19154.169% |
| Albert David Limited | 1.02 Billion INR | -14925.313% |
| Ajanta Pharma Limited | 30.46 Billion INR | -406.133% |
| Hester Biosciences Limited | 908.84 Million INR | -16864.68% |
| Valiant Laboratories Limited | 138.02 Million INR | -111602.468% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -10891.09% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -5047.286% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -1084694.202% |
| Granules India Limited | 10.31 Billion INR | -1395.053% |
| Alkem Laboratories Limited | 32.83 Billion INR | -369.565% |
| Medicamen Biotech Limited | 335.16 Million INR | -45901.486% |
| Unichem Laboratories Limited | 6.72 Billion INR | -2192.37% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -33742.598% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -2260630.205% |
| Medico Remedies Limited | 59.67 Million INR | -258269.166% |
| Ipca Laboratories Limited | 18.98 Billion INR | -712.013% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -44508.53% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -7158.401% |
| Brooks Laboratories Limited | 51.18 Million INR | -301154.005% |
| Piramal Enterprises Limited | 63.65 Billion INR | -142.223% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | -619.732% |
| Suven Life Sciences Limited | 109.75 Million INR | -140384.556% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -333944.978% |
| Strides Pharma Science Limited | 9.16 Billion INR | -1582.785% |
| Indoco Remedies Limited | 12.06 Billion INR | -1178.328% |
| Alpa Laboratories Limited | 127.38 Million INR | -120940.823% |
| Lasa Supergenerics Limited | 291.17 Million INR | -52851.775% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -4911.109% |